Insmed (INSM) Misses Q2 EPS by 2c

November 3, 2016 8:06 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.61), $0.02 worse than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Insmed (INSM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment